The DOI matches its Crossref record; 183 of the 186 references it cites were found in a registry or an index.
Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions
Open accessAbstract
Most tumors display oncogene-driven reprogramming of several metabolic pathways, which are crucial to sustain their growth and proliferation. In recent years, both dietary and pharmacologic approaches that target deregulated tumor metabolism are beginning to be considered for clinical applications. Dietary interventions exploit the ability of nutrient-restricted conditions to exert broad biological effects, protecting normal cells, organs, and systems, while sensitizing a wide variety of cancer cells to cytotoxic therapies. On the other hand, drugs targeting enzymes or metabolites of crucial metabolic pathways can be highly specific and effective, but must be matched with a responsive tumor, which might rapidly adapt. In this review, we illustrate how dietary and pharmacologic therapies differ in their effect on tumor growth, proliferation, and metabolism and discuss the available preclinical and clinical evidence in favor of or against each of them. We also indicate, when appropriate, how to optimize future investigations on metabolic therapies on the basis of tumor- and patient-related characteristics. Significance: To our knowledge, this is the first review article that comprehensively analyzes the preclinical and preliminary clinical experimental foundations of both dietary and pharmacologic metabolic interventions in cancer therapy. Among several promising therapies, we propose treatment personalization on the basis of tumor genetics, tumor metabolism, and patient systemic metabolism.Cancer Discov; 6(12); 1315–33. ©2016 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“recent studies show that personalized analysis and tailoring of metabolism open up therapeutic possibilities”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [316]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
Jones, J. I. W., & Clemmons, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,488
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., & Siuzdak, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812874106 · Cited by 2,677
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Cited by
Sorted by citations
Items 101–200 of 202
Twarock, S., Reichert, C., Bach, K., Reiners, O., Kretschmer, I., Gorski, D. J., Gorges, K., Grandoch, M., & Fischer, J. W. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14808 · Cited by 15
Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M
Aragó, M., Moreno-Felici, J., Abás, S., Rodríguez‐Arévalo, S., Hyroššová, P., Figueras, A., Viñals, F., Pérez, B., Loza, M. I., Brea, J. M., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109601 · Cited by 15
Effects of radiotherapy and short-term starvation combination on metastatic and non-tumor cell lines
Pignatta, S., Cortesi, M., Arienti, C., Zanoni, M., Cocchi, C., Sarnelli, A., Arpa, D., Piccinini, F., & Tesei, A. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102949 · Cited by 15
Withaferin A decreases glycolytic reprogramming in breast cancer
Khan, A., Rehman, A. U., Siddiqui, S., Khan, J., Massey, S., Singh, P., Saluja, D., Husain, S. A., & Iqbal, M. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-72221-5 · Cited by 14
Ligorio, F., Zambelli, L., Bottiglieri, A., Castagnoli, L., Zattarin, E., Lobefaro, R., Ottini, A., Vingiani, A., Pupa, S. M., Bianchi, G., et al. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359211006960 · Cited by 14
Self-citationZhang, E., Chen, Y., Bao, S., Hou, X., Hu, J., Mu, O. Y. N., Song, Y., & Shan, L. (2021) · Human Genomics · doi:10.1186/s40246-021-00350-3 · Cited by 13
Shende, S., Rathored, J., & Budhbaware, T. (2025) · Discover Oncology · doi:10.1007/s12672-025-02238-3 · Cited by 15
Vernieri, C., Pusceddu, S., & de Braud, F. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00902 · Cited by 12
Self-citationLushchak, O. V., Strilbyska, O., Piskovatska, V., Koliada, A. K., & Storey, K. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.62133-5 · Cited by 12
Grootveld, M. C., Percival, B. C., Page, G., Hunwin, K., Bhogadia, M., Chan, W., & Edgar, M. A. (2022) · Metabolites · doi:10.3390/metabo12090778 · Cited by 11
Wanyan, Y., Xu, X., Liu, K., Zhang, H., Zhen, J., Zhang, R., Wen, J., Liu, P., & Chen, Y. (2020) · Molecules · doi:10.3390/molecules25235778 · Cited by 11
Metabolic reprogramming and cancer precision medicine: a narrative review
Zhang, H., & Tang, S. (2021) · Precision Cancer Medicine · doi:10.21037/pcm-21-27 · Cited by 11
HIF-2α drives an intrinsic vulnerability to ferroptosis in clear cell renal cell carcinomaPreprint
Zou, Y., Palte, M. J., Deik, A., Li, H., Eaton, J. K., Wang, W., Tseng, Y., Deasy, R., Alimova, M., Dančík, V., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/388041 · Cited by 11
Žuža, M. G., Pokimica, B., Arsić, A., Ilich, J. Z., & Vučić, V. (2025) · Nutrients · doi:10.3390/nu17030456 · Cited by 9
van der Meij, B. S., Deutz, N. E. P., Rodríguez, R. E., & ENGELEN, M. P. K. J. (2020) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1941 · Cited by 9
A new metabolic signature contributes to disease progression and predicts worse survival in melanoma
Wan, M., Zhuang, B., Dai, X., Zhang, L., Zhao, F., & You, Y. (2020) · Bioengineered · doi:10.1080/21655979.2020.1822714 · Cited by 9
Non-oncogene dependencies: Novel opportunities for cancer therapy
Marco, T. D., Mazzoni, M., Greco, A., & Cassinelli, G. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116254 · Cited by 9
A whole food, plant-based diet reduces amino acid levels in patients with metastatic breast cancer
Scales, T. Q., Smith, B., Blanchard, L., Wixom, N., Tuttle, E. T., Altman, B. J., Peppone, L. J., Munger, J. C., Campbell, T. M., Campbell, E. K., et al. (2024) · Cancer & Metabolism · doi:10.1186/s40170-024-00368-w · Cited by 8
Changing landscape of optical imaging in skeletal metastases
Cho, N., & Shokeen, M. (2019) · Journal of bone oncology · doi:10.1016/j.jbo.2019.100249 · Cited by 7
Greco, G., Petrelli, A. C., Fischetti, F., & Cataldi, S. (2025) · Pathophysiology · doi:10.3390/pathophysiology32040070 · Cited by 9
Dutta, A., Thakur, S., Dey, D. K., & Kumar, A. (2024) · Cells · doi:10.3390/cells13060471 · Cited by 6
The Dichotomous Effect of Thiamine Supplementation on Tumorigenesis: A Systematic Review
Júnior, J. R. A. D. Q., Pereira, J. P. D. C., Pires, L. L., & Maia, C. S. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.2007962 · Cited by 6
Ohyama, K., Tanaka, H., & Hori, Y. (2022) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps32908 · Cited by 6
Prognostic Significance of the Comprehensive Biomarker Analysis in Colorectal Cancer
Potievskaya, V. I., Tyukanova, E. S., Sekacheva, M. I., Fashafsha, Z. Z. A., Fatyanova, A. S., Potievskiy, M. B., Kononova, E., Kholstinina, A., Polishchuk, E., Shegai, P., et al. (2025) · Life · doi:10.3390/life15071100 · Cited by 7
Current hotspots and trends in cancer metabolic reprogramming: a scientometric analysis
Yang, S., Lin, M., Hao, S., Ye, H., & Zhang, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1497461 · Cited by 5
The KRAS-G12D mutation induces metabolic vulnerability in B-cell acute lymphoblastic leukemia
Xu, Y., Fang, H., Chen, Y., Tang, Y., Sun, H., Kong, Z., Yang, F., Kirschner‐Schwabe, R., Zhu, L., Toker, A., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103881 · Cited by 6
Starving leukemia to induce differentiation
Cheng, C., & Yilmaz, Ö. H. (2017) · Nature Medicine · doi:10.1038/nm.4259 · Cited by 5
Akasha, R., Enrera, J. A., Fatima, S., Hegazy, A. M., Hussein, W., Nawaz, M., Alshammari, M. D., Almuntashiri, S., Albadari, N. G., Break, M. K. B., et al. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04018-w · Cited by 4
Ruggeri, R. M., Grossrubatscher, E. M., Ciocca, E., Hasballa, I., Jaafar, S., Oldani, M., Rubino, M., Russo, F., Isidori, A. M., Colao, A. A. L., et al. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09958-5 · Cited by 5
Chatterjee, A., Khan, R., Mukherjee, T., Sahoo, P. P., Tiwari, L. N., Singh, B. N., Kumari, R., Kumari, A., Rai, A., & Ray, S. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-04179-x · Cited by 5
Chinese Medicines for Cancer Treatment from the Metabolomics Perspective
Guo, W., Tan, H., Wang, N., & Feng, Y. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88924 · Cited by 4
Recent Trends in the Incidence of Clear Cell Adenocarcinoma and Survival Outcomes: A SEER Analysis
Guo, Y., Shrestha, A., Maskey, N., Dong, X., Zheng, Z., Yang, F., Wang, R., Ma, W., Liu, J., Li, C., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.762589 · Cited by 4
Metabonomic analysis of tumor microenvironments: a mini-review
Zeng, Z., & Chen, C.-X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1164266 · Cited by 4
Potential of Dietary HDAC2i in Breast Cancer Patients Receiving PD-1/PD-L1 Inhibitors
Wang, Y., Lu, L., Ling, C., Zhang, P., & Han, R. (2023) · Nutrients · doi:10.3390/nu15183984 · Cited by 4
Flexibility in metabolism bestows tenacious viability on cancer
Xiong, Y., Wang, L., Feng, Y., Li, X., Jia, L., & Han, Y. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.07.008 · Cited by 4
Fasting-mimicking diet: a metabolic approach for the treatment of breast cancer
Ligorio, F., Provenzano, L., & Vernieri, C. (2023) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000986 · Cited by 3
Self-citationMetabolism in Hematopoiesis and Its Malignancy
Zeng, X., Wang, Y.-P., & Man, C. H. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-7471-9_4 · Cited by 3
Serum Lipid Level in Evaluating Chinese Pancreatic Neuroendocrine Neoplasms: A Retrospective Study
Gu, D., Xue, B., Zhu, G., Xu, Y., Yan, L., Tang, Q., & Lu, C. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2229-3489 · Cited by 3
Targeting Asparagine Metabolism in Well-Differentiated/Dedifferentiated Liposarcoma
Klingbeil, K. D., Wilde, B. R., Graham, D. S., Lofftus, S. Y., McCaw, T. R., Matulionis, N., Dry, S., Crompton, J. G., Eilber, F. C., Graeber, T. G., et al. (2024) · Cancers · doi:10.3390/cancers16173031 · Cited by 3
Therapeutic Targeting of Glutamine Metabolism in Colorectal Cancer
Ratre, Y. K., Verma, H. K., Mehta, A., Soni, V. K., Sonkar, S. C., Shukla, D., Ekka, A., Prajapati, S. K., Mahilkar, S., & Vishvakarma, N. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-64668-4_15 · Cited by 4
Li, N., Wang, G., Guo, M., Zhu, N., & Yu, W. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150046 · Cited by 2
Higher order synthetic lethals are keys to minimize cancer treatment effects on non-tumor cells
Manshadi, M. D., Setoodeh, P., Ramezani, A., Rajabzadeh, A. R., & Zare, H. (2026) · PLoS ONE · doi:10.1371/journal.pone.0342199 · Cited by 2
Al-Jada, D. N., Takruri, H. R., Talib, W. H., Hajeer, M., Alsafadi, D. B., Shahin, N. A., & Ahram, M. A. (2025) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1177/1973798x251391703 · Cited by 2
Intermittent fasting enhances cisplatin-metformin efficacy in therapy-resistant ovarian cancer PDXs
Capellini, E., Perotti, L., Guffanti, F., Simone, G. D., Morabito, A., Ronchi, A. M., Sala, L., Scanziani, E., Corna, D., Cerullo, D., et al. (2025) · iScience · doi:10.1016/j.isci.2025.114300 · Cited by 2
Interactions between nutrition and the epigenome: how can it be harnessed for public health?
Anastasopoulou, M., Dereki, I., Sgourou, A., & Lagoumintzis, G. (2026) · Future Science OA · doi:10.1080/20565623.2026.2641015 · Cited by 5
Dietary Compounds Drive Epigenetic Regulation and Modifications in Blood Cancer: A Critical Review
Ikhtiar, F., Jamal, A., Kiran, S., & Hossain, M. B. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70471 · Cited by 2
Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting
Santis, F. D., Vecchio, M. D., Castagnoli, L., de Braud, F., Cosimo, S. D., Franceschini, D., Fucà, G., Hiscott, J. B., Malmberg, K., McGranahan, N., et al. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.10.005 · Cited by 2
Self-citationHarnessing the ROS for Cancer Treatment
Osama, A., Zhang, J., & Fang, J. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_255-1 · Cited by 2
Bu, L., Zhang, Y., Su, Y., Wu, X., Gao, B. X., Wang, L., Xie, W., Jiang, Q., & Guo, J. (2025) · Gut · doi:10.1136/gutjnl-2024-334630 · Cited by 2
Fidelle, M., Derosa, L., Routy, B., & Zitvogel, L. (2021) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2021.01.022 · Cited by 2
Wang, C., Gao, X., Wang, F., Guan, W., Dou, H., & Xu, G. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s283430 · Cited by 2
Lu, Y., Zhou, X., Liu, Z., Wang, W., Lu, S., & Fu, W. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.49576 · Cited by 2
[A Review of the Redox Regulation of Tumor Metabolism].
Wang, K., Ming, H., Zuo, J., Tian, H., & Huang, C. (2021) · PubMed Central · doi:10.12182/20210160204 · Cited by 2
Metabolic dysregulation in cancer progression
Arfin, S., Agrawal, K., Kumar, A., Kumar, A. J., Rathi, B., & Kumar, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99879-6.00008-0 · Cited by 2
“Systemic Strategy at the Patient's Service”: A Congress Report on Supportive Care in Oncology
Nichetti, F., Lobefaro, R., Pagani, F., Randon, G., Corti, F., de Braud, F., Celio, L., & Platania, M. (2017) · Tumori Journal · doi:10.5301/tj.2017.17342 · Cited by 1
Zhu, Y., Lin, X., Wang, T., Wang, S., Wang, W., Ming, K., Zhu, Y., Zhang, B., Ofosuhemaa, P., Wang, Y., et al. (2025) · BioMetals · doi:10.1007/s10534-025-00684-8 · Cited by 1
Targeting Metabolic Reprogramming: A New Frontier in Cancer Therapy
Thakur, R. K., & Kumari, N. (2025) · Springer eBooks · doi:10.1007/978-981-96-7336-0_9 · Cited by 1
Wang, T., Zhang, D., Jin, C., Xu, H., Nie, H., Wang, Y., Zhang, C., Feng, Y., Tang, J., & Sun, Y. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.10.025 · Cited by 1
The Role of One‐Carbon Metabolism in Cancer and Its Therapeutic Significance
Jiang, Y., Zhou, G., Zhang, Q., & Zhou, S. (2026) · MedComm – Oncology · doi:10.1002/mog2.70062 · Cited by 1
Karimi, K., Roberts, S. C., Carter, N. S., Hofer, S. J., & Karimi, R. (2026) · Amino Acids · doi:10.1007/s00726-026-03512-6 · Cited by 1
de Melo, V. C., Sales, G. S., de Moura, J. L. N., Bagatini, M. D., & da Silva, G. B. (2026) · Clinical bioenergetics · doi:10.3390/clinbioenerg2020008 · Cited by 1
Cai, Y., Jin, J., Wang, Y., Han, D., Yu, X., Jin, F., Li, M. D., Li, Y., & Li, X. (2026) · BMC Medicine · doi:10.1186/s12916-026-04898-6 · Cited by 1
Cancer Prevention and Treatment Based on Lifestyles
Amraiz, D., Kiani, A. K., Awan, U. A., Amraiz, T., Awan, B., & Irfan, M. (2024) · Cancer treatment and research · doi:10.1007/978-3-031-55622-7_10 · Cited by 1
Regulation of Energy Homeostasis in Cancer
Tetik, Ş. (2022) · Advances in Pharmacology & Clinical Trials · doi:10.23880/apct-16000199
Beyond Computational Genomics towards Systems Metabolomics for Precision OncologyPreprint
Alberghina, L. (2018) · Preprints.org · doi:10.20944/preprints201808.0127.v1
Role of lipid droplets and FITM2 in beta-cell physiology and pathophysiology
Ho, C. Q. W. (2022) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/158047 · Cited by 1
Association of Dyslipidemia, Renal dysfunction, and Uricemia with HPV mediated Cervical CancerPreprint
Kushwah, A. S., Mishra, R., Srivast, K., Mishra, S., & Banerjee, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1821603/v1 · Cited by 1
Mitochondria Remodeling in Cancer
Dornfeld, K. J., & Skildum, A. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-73344-9_9
Recent Trends in the Incidence of Clear Cell Adenocarcinoma and Survival Outcomes: A SEER AnalysisPreprint
Shrestha, A., Maskey, N., Dong, X., Zheng, Z., Yang, F., Wang, R., Ma, W., Liu, J., Li, C., Zhang, W., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-121162/v1
Cancer Risk Assessment and Screening; A Challenge for Clinical Pathology Service?
Kresno, S. B. (2020) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v27i1.1660
Breath acetone as a potential marker of metabolic flexibility
Ivanova, A. M., & Ginak, A. I. (2020) · Butlerov Communications · doi:10.37952/roi-jbc-01/20-61-1-111
Redox Regulation of Metabolic Enzymes in Cancer
Jiang, J., & Huang, C. (2021) · Springer eBooks · doi:10.1007/978-981-16-0522-2_11
Iron induced qualitative enhancement in lipid profile of the cyanobacterium Anabaena sphaerica
Kunui, K., Minj, R. A., Mishra, A. K., & Singh, S. S. (2021) · Vegetos · doi:10.1007/s42535-021-00307-w
Research trends of cancer metabolism: analysis from a Chinese perspective
Li, Y., Liu, J., Sun, L., Zhang, B., & Shi, R. (2022) · 癌症：英文版 · doi:10.1002/cac2.12293
The Clinical Value of Lipid Abnormalities in Cervical CancerPreprint
Li, A., Wang, L., Jin, M., Shou, Y., Zheng, F., & Zhu, H. (2020) · doi:10.21203/rs.3.rs-118805/v1
Olive, D. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737700843.793574171
Zheng, Z., Li, Z., Guan, J.-L., Liu, X., Li, J., Chen, Y., Lin, L., Kou, J., Lv, J., Zhang, L., et al. (2023) · doi:10.1158/0008-5472.c.6511960
Zheng, Z., Li, Z., Guan, J.-L., Liu, X., Li, J., Chen, Y., Lin, L., Kou, J., Lv, J., Zhang, L., et al. (2023) · doi:10.1158/0008-5472.c.6511960.v1
Effects of Cancer Drugs and Their Metabolism in Our Body
K.Malleswari, -, D. R. B. R., -, V. P. K., -, A. S. J. B., & Santhosh, B. (2023) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2023.v05i04.5534
Giugliano, F., Boldrini, L., Uliano, J., Crimini, E., Minchella, I., & Curigliano, G. (2023) · Cancer treatment and research · doi:10.1007/978-3-031-33602-7_8
Metabolic Pathways in Pediatric Cancers
Salmanpour, F., Alijanzadeh, D., Ghobadinezhad, F., Samieefar, N., Piryaee, M., Bajestani, Z. H., Akhlaghdoust, M., Keyvanfar, M., & Kelishadi, R. (2024) · Springer eBooks · doi:10.1007/978-3-030-80962-1_402-1
Brunelli, L., Guffanti, F., Simone, G. D., Morabito, A., Fruscio, R., Perotti, L., Capellini, E., Pastorelli, R., Damia, G. L. M., & Ricci, F. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4828026
Ssedyabane, F., Randall, T. C., Ngonzi, J. N. J., Kajabwangu, R., Namuli, A., Muhumuza, J., Najjuma, J. N., & Tusubira, D. (2024) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v13i1.2374
Clinical implications of resistance to anti-HER2 antibodies in breast cancer
Dhanisha, S. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-816408-2.00005-1
Tumor metabolism and anti-tumor immunity
Serganova, I. S., & Zappasodi, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00018-7
O-GlcNAcylation and Cell Metabolism
Ruan, Y. (2024) · Springer eBooks · doi:10.1007/978-981-97-4864-8_3
Que, L., Liu, Z., Wu, Y., Luo, L., & Liang, L. (2025) · SAGE Open Medicine · doi:10.1177/20503121251341114
Metabolic Pathways in Pediatric Cancers
Salmanpour, F., Alijanzadeh, D., Ghobadinezhad, F., Samieefar, N., Piryaee, M., Bajestani, Z. H., Akhlaghdoust, M., Keyvanfar, M., & Kelishadi, R. (2025) · Springer eBooks · doi:10.1007/978-3-032-00771-1_402 · Cited by 1
Banerjee, S., Banerjee, A., Singhvi, G., Taliyan, R., & Dhar, P. (2025) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-025-00706-x
Legal perspectives on green-synthesized sustainable antibacterial solutions: a review
Cherian, P., John, B., Bhagya, D., Joseph, P., Thomas, S., Nisha, S. K., & Mol, G. P. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33761-1.00010-6
Ray, P., Chakraborty, T., Roy, S., & Adak, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33459-7.00009-0
Tong, C., Wang, W., & He, C. (2022) · Figshare · doi:10.6084/m9.figshare.19305056
Harnessing the ROS for Cancer Treatment
Osama, A., Zhang, J., & Fang, J. (2025) · Springer eBooks · doi:10.1007/978-3-032-00771-1_255
Zerbo, G., Bonacci, P. G., Terrana, M., Greco, V., Cavallaro, G., Bonaccorso, C., Giuffrida, A., Fortuna, C. G., & Musso, N. (2026) · Foods · doi:10.3390/foods15020205
Sawant, P., Jain, R., & Dandekar, P. P. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108030
Introduction to metabolic targets and autophagy
Desai, H., Buttar, R. K., & Gawali, P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44041-0.00011-8
Chen, Y., Gui, T. T., Huang, Z., Quach, N. E., Tu, S., Liu, J., Garrett, T. J., Starkweather, A. R., Lyon, D., Shepherd, B. E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.13.718341
Introduction to Cancer Metabolism
Mohan, G., Meena, M., Manzer, S. H., Raturi, G., Janmeda, P., & Chaudhary, P. (2026) · Cancer treatment and research · doi:10.1007/978-3-032-21861-2_1
Chen, Y., Fang, Y., Zhao, G., Zhou, Y., Yang, D.-H., Han, J., & Zheng, Y. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218649
You, K., Gupta, R., Bucci, J. A., Wang, Q., & Ni, J. (2026) · Cancer Heterogeneity and Plasticity · doi:10.47248/chp2603030010
Metadata
- Authors
- Vernieri, C., Casola, S., Foiani, M., Pietrantonio, F., de Braud, F., & Longo, V.
- Affiliations
- IFOM (IT)
- University of Milan (IT)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- University of Southern California (US)
- Corresponding author
- Vernieri, Claudio
- Longo, Valter
- ORCID
- Venue
- Cancer Discovery
- Published
- 2016-12-01
- Volume
- 6
- Issue
- 12
- Pages
- 1315-1333
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC5140697
- OpenAlex
- W2554098255
- Cited by
- 202
- References
- 186
- Citations by year
- 2026: 16 · 2025: 21 · 2024: 22 · 2023: 18 · 2022: 20 · 2021: 24 · 2020: 28 · 2019: 20 · 2018: 21 · 2017: 12
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Funders
- National Institute on Aging (P01AG034906)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cancer metabolism, tumor metabolic reprogramming, dietary intervention, nutrient restriction, metabolic therapy, personalized treatment, cancer genetics, drug resistance
- MeSH terms
- Antineoplastic Agents, Cell Survival, Combined Modality Therapy, Diet Therapy, Humans, Neoplasms, Cell Proliferation, Metabolic Networks and Pathways, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
